Early complete response of primary bone marrow B-cell lymphoma treated with rituximab-based CHOP therapy, assessed by flow cytometry and immunogloblin heavy chain rearrangement.
Yoshimi NabeShohei KikuchiYusuke KamiharaAkinori WadaJun MurakamiTsutomu SatoPublished in: Clinical case reports (2021)
Evaluation of early response by flow cytometry and immunogloblin heavy chain assessments against primary bone marrow B-cell lymphoma could be valuable for predicting treatment outcome.